Ribociclib + Sensitive Cyp3a Substrates Interaction
Moderateinteraction on record
Description
KISQALI increases exposure of CYP3A4 substrates. Monitor for increased adverse reactions and consider dose reduction of the CYP3A substrate.
Mechanism
KISQALI inhibits CYP3A4, increasing substrate exposure
Source: NLP:ribociclib